Hydrolytic polysorbate 20 degradation – Sensitive detection of free fatty acids in biopharmaceuticals via UPLC-QDa analytics with isolator column
Dirk-H. Evers(Bio-Rad (Germany)), Julia Buske(Boehringer Ingelheim (Germany)), Dániel Lakatos(Boehringer Ingelheim (Germany)), Frank Hämmerling(Boehringer Ingelheim (Germany)), Patrick Garidel(Boehringer Ingelheim (Germany)), Stefan Carle(Boehringer Ingelheim (Germany))
Cited by 14
Related Papers
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates
|Pharmaceutics|2022|93
A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery
|International Journal of Pharmaceutics|2017|55
An in-depth examination of fatty acid solubility limits in biotherapeutic protein formulations containing polysorbate 20 and polysorbate 80
|International Journal of Pharmaceutics|2020|47
The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells
|Scientific Reports|2017|42
Assessing the polysorbate degradation fingerprints and kinetics of lipases – how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions
|European Journal of Pharmaceutical Sciences|2021|37